JPS62502967A - 非潰瘍消化不良症の治療 - Google Patents

非潰瘍消化不良症の治療

Info

Publication number
JPS62502967A
JPS62502967A JP61502999A JP50299986A JPS62502967A JP S62502967 A JPS62502967 A JP S62502967A JP 61502999 A JP61502999 A JP 61502999A JP 50299986 A JP50299986 A JP 50299986A JP S62502967 A JPS62502967 A JP S62502967A
Authority
JP
Japan
Prior art keywords
antibiotics
bismuth salt
antibiotic
amoxicillin
ulcer dyspepsia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61502999A
Other languages
English (en)
Japanese (ja)
Inventor
ボロデイ−，ト−マス・ジユリウス
Original Assignee
ザ・プロクター・アンド・ギャンブル・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3771057&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS62502967(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ザ・プロクター・アンド・ギャンブル・カンパニー filed Critical ザ・プロクター・アンド・ギャンブル・カンパニー
Publication of JPS62502967A publication Critical patent/JPS62502967A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP61502999A 1985-04-18 1986-04-18 非潰瘍消化不良症の治療 Pending JPS62502967A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH019885 1985-04-18
AU0198 1985-04-18

Publications (1)

Publication Number Publication Date
JPS62502967A true JPS62502967A (ja) 1987-11-26

Family

ID=3771057

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61502999A Pending JPS62502967A (ja) 1985-04-18 1986-04-18 非潰瘍消化不良症の治療

Country Status (5)

Country Link
EP (1) EP0222834A4 (fr)
JP (1) JPS62502967A (fr)
AU (1) AU590578B2 (fr)
SG (1) SG72632A1 (fr)
WO (1) WO1986005981A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06184186A (ja) * 1990-03-07 1994-07-05 Pliva Pharmaceut & Chem Works 抗潰瘍剤、抗生物質の錯体又はキレート及びその製造方法

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135582T1 (de) * 1985-06-13 1996-04-15 Barry James Marshall Verfahren und zusammensetzungen zur behandlung von gastrointestinalen störungen
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
AU623868B2 (en) * 1987-10-12 1992-05-28 Capability Services Pty. Limited Improved method for treatment of gastrointestinal disorders
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
EP0375068A1 (fr) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Associations de composés de bismuth et de tétracyclines
EP0403048A3 (fr) * 1989-06-14 1991-01-30 Warner-Lambert Company Un modèle de structure de système craniomandibulaire humain
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DE59309771D1 (de) * 1993-05-11 1999-10-14 Spirig Ag Festes bismut- und amoxycillinhaltiges Arzneipräparat und seine Verwendung
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
PE48297A1 (es) * 1995-05-09 1998-02-04 Procter & Gamble Metodos y composiciones para la prevencion y el tratamiento de desordenes gastrointestinales
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
MX355760B (es) 2010-12-13 2018-04-27 Salix Pharmaceuticals Inc Formulaciones gástricas y colónicas y métodos para elaborar y usar las mismas.
DK2877163T3 (en) 2012-07-27 2019-04-15 Redhill Biopharma Ltd FORMULATIONS AND PROCEDURES FOR THE PREPARATION OF FORMS FOR USING GAS DRAINAGE

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2053002A1 (en) * 1969-06-21 1971-04-16 Clin Midy Bismuth slats of alpha methiminobenzyl - penicillin
JPS50116623A (fr) * 1974-01-18 1975-09-12
JPS54135219A (en) * 1978-02-24 1979-10-20 Novex Foreign Trade Co Ltd Orally dosing solid pharmaceutical preparation and production
JPS58501590A (ja) * 1981-09-22 1983-09-22 ギスト　ブロカデス　ナ−ムロ−ゼ　フエンノ−トチヤツプ ビスマス含有組成物及び該組成物の製造方法
JPS60104013A (ja) * 1983-10-13 1985-06-08 リチヤ−ドソン−ヴイツクス　インコ−ポレ−テツド 下痢止め組成物とその使用
JPS6248623A (ja) * 1985-06-13 1987-03-03 バリ−、ジエ−ムズ、マ−シヤル 胃腸疾患の治療のための医薬組成物
JPS6248624A (ja) * 1985-06-13 1987-03-03 バリ−、ジエ−ムズ、マ−シヤル 胃腸疾患の治療用医薬組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6063965A (en) * 1965-06-25 1967-01-05 Morton W. Scott Belayed acting compositions
US3621094A (en) * 1968-04-05 1971-11-16 Smith Kline French Lab Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts
GB1269987A (en) * 1968-04-18 1972-04-12 Garland Richard Brown Antacid composition
GB1220819A (en) * 1968-04-24 1971-01-27 Mar Pha Soc D Etude Et D Expl Improved bismuth salt
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
FR2029402A1 (fr) * 1969-01-28 1970-10-23 Breive Et Son Jib Labo Produit destiné à régulariser la digestion dans l'estomac et l'intestin
FR2073254A2 (en) * 1969-12-04 1971-10-01 Dausse Laboratoire Gum guar stabilised suspensions - of insoluble medicaments for treati gastrointestinal disorders
AU440535B2 (en) * 1969-12-18 1973-09-17 Export Drugs Company Antacid compositions
FR2092636A1 (en) * 1970-06-03 1972-01-28 Griffon Henri Dried yeast - bismuth subnitrate compositions - for gastrointestinal disorders

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2053002A1 (en) * 1969-06-21 1971-04-16 Clin Midy Bismuth slats of alpha methiminobenzyl - penicillin
JPS50116623A (fr) * 1974-01-18 1975-09-12
JPS54135219A (en) * 1978-02-24 1979-10-20 Novex Foreign Trade Co Ltd Orally dosing solid pharmaceutical preparation and production
JPS58501590A (ja) * 1981-09-22 1983-09-22 ギスト　ブロカデス　ナ−ムロ−ゼ　フエンノ−トチヤツプ ビスマス含有組成物及び該組成物の製造方法
JPS60104013A (ja) * 1983-10-13 1985-06-08 リチヤ−ドソン−ヴイツクス　インコ−ポレ−テツド 下痢止め組成物とその使用
JPS6248623A (ja) * 1985-06-13 1987-03-03 バリ−、ジエ−ムズ、マ−シヤル 胃腸疾患の治療のための医薬組成物
JPS6248624A (ja) * 1985-06-13 1987-03-03 バリ−、ジエ−ムズ、マ−シヤル 胃腸疾患の治療用医薬組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06184186A (ja) * 1990-03-07 1994-07-05 Pliva Pharmaceut & Chem Works 抗潰瘍剤、抗生物質の錯体又はキレート及びその製造方法

Also Published As

Publication number Publication date
EP0222834A4 (fr) 1989-10-04
AU590578B2 (en) 1989-11-09
SG72632A1 (en) 2000-05-23
EP0222834A1 (fr) 1987-05-27
WO1986005981A1 (fr) 1986-10-23
AU5902686A (en) 1986-11-05

Similar Documents

Publication Publication Date Title
JPS62502967A (ja) 非潰瘍消化不良症の治療
KR960016582B1 (ko) 위장장해의 치료 및 예방용 약제학적 조성물
RU2141844C1 (ru) Фармацевтическое соединение
US5256684A (en) Methods and compositions for the treatment of gastrointestinal disorders
US5407688A (en) Compositions and methods for treating gastrointestinal disorders
EP0858804B1 (fr) Utilisation de la rifaximine comme médicament pour le traitement des diarrhées causées par les Cryptosporidies
EP0533281B1 (fr) Utilisation de ranitidine bismuth citrate en combinaison avec claritromycin ou claritromycin et tetracycline, pour la fabrication d'un médicament pour le traitement des maladies gastrointestinales
JPS58134031A (ja) 多発性硬化症処置におけるジヒドロシクロスポリンｄ
US2438106A (en) Peroral penicillin compositions
EP0219912B1 (fr) L'utilisation du nitrofurantoine pour le traitement et la prophylaxie des maladies gastro-intestinales
US6426369B1 (en) Oxethazaine as antimicrobial agent
JPH07188030A (ja) 薬剤の製造のためのモエノマイシンおよびその誘導体並びにこれらを含有する薬剤
AU8424091A (en) Pharmaceutical compositions containing 5-difluoromethoxy-2-{(3,4-dimethoxy-2-pyridyl) methylsulfinyl} benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders
WO2020096328A1 (fr) Composition pharmaceutique pour prévenir ou traiter l'obésité, contenant cyclo(his-pro) en tant que substance active
JPH07242560A (ja) 抗菌剤
US4650668A (en) Composition for relieving toothache pain and other forms of intense pain
CN111184867A (zh) 治疗幽门螺杆菌感染的化学药物组合物
Ali Principles of drug therapy in dentistry
US5686095A (en) Method of treating canker sores
JP2002265354A (ja) 抗ピロリ菌剤組成物
Schoemperlen MUCOSAL RESPIRATORY SYNDROME
JPH11189529A (ja) 抗ヘリコバクター・ピロリ剤
RU2102970C1 (ru) Способ лечения глубокого кариеса зубов
SU1715359A1 (ru) Способ лечени аллергических заболеваний
JPH0143725B2 (fr)